3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-N,N-diethyl-4-oxo-3H-imidazo[4,5-c]pyridine-5(4H)-carboxamide

ID: ALA2281583

PubChem CID: 76316145

Max Phase: Preclinical

Molecular Formula: C29H32N8O2

Molecular Weight: 524.63

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCc1nc2ccn(C(=O)N(CC)CC)c(=O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

Standard InChI:  InChI=1S/C29H32N8O2/c1-4-7-12-25-30-24-17-18-36(29(39)35(5-2)6-3)28(38)26(24)37(25)19-20-13-15-21(16-14-20)22-10-8-9-11-23(22)27-31-33-34-32-27/h8-11,13-18H,4-7,12,19H2,1-3H3,(H,31,32,33,34)

Standard InChI Key:  UADAKUBGKZSBRB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
   25.8444  -11.1916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5541  -10.7822    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.5513   -9.9595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8426   -9.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1364  -10.7826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1376   -9.9661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3614   -9.7126    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.8804  -10.3725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3594  -11.0337    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.8442  -12.0088    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.1058  -11.8105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6517  -12.4186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3965  -13.1920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9417  -13.7997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7422  -13.6313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9947  -12.8496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4478  -12.2452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2863  -14.2337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0320  -15.0115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5780  -15.6186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3783  -15.4490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6297  -14.6670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0821  -14.0633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2317  -15.1817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6238  -14.6372    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.9152  -15.0464    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.0854  -15.8468    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.8992  -15.9321    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.2624  -11.1896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9695  -10.7799    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.0632  -10.3713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6557   -9.6630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8385   -9.6618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4309   -8.9535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2637  -12.0068    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.6779  -11.1874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9682   -9.9627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6753   -9.5530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3849  -10.7777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  1 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 15 18  1  0
 19 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 24  1  0
  2 29  1  0
 29 30  1  0
  8 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 29 35  2  0
 30 36  1  0
 30 37  1  0
 37 38  1  0
 36 39  1  0
M  END

Associated Targets(non-human)

Agtr1b Angiotensin II receptor (AT-1) type-1 (1480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 524.63Molecular Weight (Monoisotopic): 524.2648AlogP: 4.75#Rotatable Bonds: 9
Polar Surface Area: 114.59Molecular Species: ACIDHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.23CX Basic pKa: 1.75CX LogP: 4.76CX LogD: 3.16
Aromatic Rings: 5Heavy Atoms: 39QED Weighted: 0.30Np Likeness Score: -1.37

References

1. Sharma MC, Kohli DV.  (2013)  A comprehensive structureactivity analysis 2,3,5-trisubstituted 4,5-dihydro-4-oxo-3H-imidazo [4,5-c] pyridine derivatives as angiotensin II receptor antagonists: using 2D- and 3D-QSAR approach,  22  (2): [10.1007/s00044-012-0040-z]

Source